The goal of this activity is for learners to be better able to understand the biological and clinical rationale for therapies used to treat mCRC, to enhance their ability to stay up to date with new and emerging data, to increase awareness of treatment-related adverse events and elevate their confidence in implementing these therapies into practice.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1001206
- Start Date: 2024-06-20 05:00:00
- End Date: 2024-06-20 05:00:00
- Credit Details: IPCE Credits: 1.5 hours
AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - MOC Credit Details: ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Takeda Pharmaceuticals (Any division) - Amount: 74582.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Gastroenterology, Medical Oncology
Subscribe
Login
0 Comments
Oldest